The exponential increase in demand to manufacture therapeutics including vaccines triggered by the pandemic has stressed the supply chain for single-use products.

It would be easy to say that the pandemic has driven dramatic growth for CDMO companies, as more pharmaceutical firms seek to outsource. Really though, the trend started much earlier, with many CDMOs having put their massive expansion plans in place a year or more before the pandemic took hold.

The ISPE South Central Chapter recently hosted their Inaugural South Central Chapter Education Seminar from College Station, while live-streaming in Austin, Houston, Dallas-Fort Worth Area (DFW), and The University of Oklahoma. Each city hosted an in-person networking dinner followed by the sessions on Vaccine/Gene Therapy Manufacturing and Writing User Requirements Specifications.

mRNA is back at the 2022 ISPE Biotechnology Conference. Last year we learned from major key players about their journey to develop first time mRNA vaccines against COVID-19 and build manufacturing capacity for billions of doses in less than one year. In 2022 we are revising the relevance of mRNA technology and widening the view beyond the COVID vaccine.

ISPE’s ICH Q12 Implementation Team, a technical team under the auspices of ISPE’s Product Quality Lifecyle Implementation (PQLI)® committee, recently worked with Health Canada (HC) to develop and...

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)’s Quality Risk Management (QRM) guidance was signed off by ICH in November 2005 as one of a suite of guidelines alongside Q8, Pharmaceutical Development, Q10, Pharmaceutical Quality System and later, Q11, Development and Manufacture of Drug Substances, which describe the science- and...

ISPE’s Analytical Method Strategy/ICH Q2(R2) & Q14 team, a working group within ISPE’s Product Quality and Lifecycle Implementation (PQLI)® Committee, to lead ISPE’s comments on the ICH documents to regulatory authorities.

A panel discussion held on 26 April during the 2022 ISPE Europe Annual Conference focused on Sustainability, Annex 1 Revision Implementation, and Good Engineering Practice and highlighted the many linkages...

A panel discussion held on 27 April 2022 during the 2022 ISPE Europe Annual Conference focused on Digital Transformation.

Think Tanks are meant to mobilize expertise and ideas to influence processes and procedures and help address global issues – a concept perfectly in line with the goals and mission of ISPE, the pharmaceutical industry’s largest nonprofit association committed to connecting over 20,000 peers across 90 countries. Through online and in-person forums, ISPE members can gain industry knowledge, learn...

In 2022, supply chain challenges have been present in the news every day. Whether it is oil, computer chips, drugs, or baby formula, we have been made aware about how fragile our supply chains are and how many companies are hard at work trying to shore up current supply lines, while preparing for a better future with innovative solutions. Within our own industry, supply chain issues and...

Paperless Validation is a current topic of interest within the pharmaceutical industry with many companies now adopting or planning to adopt digital solutions with the promise of improved data integrity and more compliant execution of testing activities.

Featured in this edition of iSpeak Reading Roundup, are the top blog posts from April 2022. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last month.

Knowledge management is a vital tool for sustaining competitive advantage and improving performance. It is the conscious process of acquiring, analyzing, storing, and disseminating information related to products, manufacturing processes, and components.

We would like to thank the judges of the 2022 Facility of the Year Awards (FOYA) program. The FOYA program has proven to be the premier global awards program focused on recognizing innovation and creativity in the...

The life sciences industry has always been focused on innovation. Pharmaceutical and biotech companies are constantly searching for new compounds to help cure or vaccinate against diseases or alleviate symptoms of other ailments. They spend billions on research and development, and they are all working towards blockbuster therapies that can improve people's lives worldwide. However, the period...

Meet volunteers from Affiliates/Chapters and Women in Pharma®.

Meet ISPE Emerging Leader volunteers and the 2022 Europe Hackathon Committee.